100 related articles for article (PubMed ID: 13129406)
1. A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length.
He J; Liu G; Zhang S; Vanderheyden JL; Liu N; Liu C; Zhang Y; Gupta S; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2003; 14(5):1018-23. PubMed ID: 13129406
[TBL] [Abstract][Full Text] [Related]
2. Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications.
Mang'era KO; Liu G; Yi W; Zhang Y; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
Eur J Nucl Med; 2001 Nov; 28(11):1682-9. PubMed ID: 11702111
[TBL] [Abstract][Full Text] [Related]
3. Optical pretargeting of tumor with fluorescent MORF oligomers.
He J; Rusckowski M; Wang Y; Dou S; Liu X; Zhang S; Liu G; Hnatowich DJ
Mol Imaging Biol; 2007; 9(1):17-23. PubMed ID: 17171474
[TBL] [Abstract][Full Text] [Related]
4. Radiolabeling morpholinos with 90Y, 111In, 188Re and 99mTc.
Liu CB; Liu GZ; Liu N; Zhang YM; He J; Rusckowski M; Hnatowich DJ
Nucl Med Biol; 2003 Feb; 30(2):207-14. PubMed ID: 12623121
[TBL] [Abstract][Full Text] [Related]
5. Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF.
He J; Wang Y; Dou S; Liu X; Zhang S; Liu G; Hnatowich D
Mol Pharm; 2010 Aug; 7(4):1118-24. PubMed ID: 20507096
[TBL] [Abstract][Full Text] [Related]
6. Affinity enhancement bivalent morpholino for pretargeting: initial evidence by surface plasmon resonance.
He J; Liu G; Vanderheyden JL; Dou S; Mary R; Hnatowich DJ
Bioconjug Chem; 2005; 16(2):338-45. PubMed ID: 15769087
[TBL] [Abstract][Full Text] [Related]
7. Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
Liu G; Mang'era K; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
J Nucl Med; 2002 Mar; 43(3):384-91. PubMed ID: 11884499
[TBL] [Abstract][Full Text] [Related]
8. Affinity enhancement bivalent morpholinos for pretargeting: surface plasmon resonance studies of molecular dimensions.
He J; Liu X; Zhang S; Liu G; Hnatowich DJ
Bioconjug Chem; 2005; 16(5):1098-104. PubMed ID: 16173785
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics in mice of four oligomer-conjugated polymers for amplification targeting.
He J; Liu G; Zhang S; Rusckowski M; Hnatowich DJ
Cancer Biother Radiopharm; 2003 Dec; 18(6):941-7. PubMed ID: 14969606
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice.
Vanderheyden JL; Liu G; He J; Patel B; Tait JF; Hnatowich DJ
Nucl Med Biol; 2006 Jan; 33(1):135-44. PubMed ID: 16459269
[TBL] [Abstract][Full Text] [Related]
11. The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in mice.
Liu G; Zhang S; He J; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
Q J Nucl Med; 2002 Sep; 46(3):233-43. PubMed ID: 12134139
[TBL] [Abstract][Full Text] [Related]
12. Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor.
Liu G; He J; Dou S; Gupta S; Rusckowski M; Hnatowich DJ
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1115-23. PubMed ID: 16133391
[TBL] [Abstract][Full Text] [Related]
13. Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake.
Liu G; He J; Dou S; Gupta S; Vanderheyden JL; Rusckowski M; Hnatowich DJ
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):417-24. PubMed ID: 14691611
[TBL] [Abstract][Full Text] [Related]
14. Comparison of several linear fluorophore- and quencher-conjugated oligomer duplexes for stability, fluorescence quenching, and kinetics in vitro and in vivo in mice.
Zhang S; Liu G; Liu X; Yin D; Dou S; He J; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2007; 18(4):1170-5. PubMed ID: 17511492
[TBL] [Abstract][Full Text] [Related]
15. An improved method for covalently conjugating morpholino oligomers to antitumor antibodies.
He J; Liu G; Dou S; Gupta S; Rusckowski M; Hnatowich D
Bioconjug Chem; 2007; 18(3):983-8. PubMed ID: 17385902
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting.
Chen X; Dou S; Liu G; Liu X; Wang Y; Chen L; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2008 Aug; 19(8):1518-25. PubMed ID: 18646837
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
18. In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA).
Mardirossian G; Lei K; Rusckowski M; Chang F; Qu T; Egholm M; Hnatowich DJ
J Nucl Med; 1997 Jun; 38(6):907-13. PubMed ID: 9189140
[TBL] [Abstract][Full Text] [Related]
19. Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept.
He J; Liu G; Gupta S; Zhang Y; Rusckowski M; Hnatowich DJ
J Nucl Med; 2004 Jun; 45(6):1087-95. PubMed ID: 15181145
[TBL] [Abstract][Full Text] [Related]
20. Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.
Liu G; Dou S; He J; Liu X; Rusckowski M; Hnatowich DJ
Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):237-46. PubMed ID: 17021815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
